When we compared the NES mRNA fold change gene expression in all tissues examined, we detected a significantly higher expression score in BRAF+ melanoma than in dysplastic nevus (p = 0.0357) and melanoma in situ (p = 0.0367) (Figure 3b). This evidence concerns the gene BRAF and in situ carcinoma.